Harmful constituents of herbs

1. De Smet P.A.G.M.: Adverse effects of herbal drugs (vol.1). Springer Verlag, Berlin 1992. 2. Newall C.A., Anderson L.A., Phillipson J.D.: Herbal Medicines. A guide for health-care professionals. The Pharmaceutical Press, London 1996. 3. EMEA/HMPC/246736/05. Public statement on "CPMP list of herbal drugs with serious risks, dated 1992”. EMEA, London 2005. 4. Henneberg M., Skrzydlewska E.: Zatrucia roślinami wyższymi i grzybami. PZWL, Warszawa 1984. 5. Ridker P.M., Ohkuma S., McDermott W.V. et al.: Hepatic venocclusive disease associated with the consumption of pyrrolizidine-containing dietary supplements. Gastroenterology 1985, 88,1050. 6. Weston C.F.M., Cooper B.T., Davies J.D. et al.: Veno-occlusive disease of the liver secondary to the ingestion of comfrey. Br. Med. J. 1987, 295, 183. 7. Kohlmünzer S.: Farmakognozja. Wydawnictwo Lekarskie PZWL, 2003. 8. Siegers C.P.: Cytotoxicity of alkylphenols from Ginkgo biloba. Phytomedicine 1999, 6, 281. 9. Blumenthal M., Busse W.R., Goldberg A. et al.: The Complete German Commission E Monographs-Therapeutic Guide to Herbal Medicines. American Botanical Council, Boston 1998. 10. De Smet P.A.G.M.: Health risks of herbal remedies. Drug Safety 1995. 13. 81. 11. Kawasaki Y., Goda Y., Yoshihira K.: The mutagenic constituents of Rubia tinctorum. Chem. Pharm. Bull. 1992, 40, 1504. 12. De Smet P.A.G.M.: Towards safer herbal medicines. The European Phytojournal, 1996. 13. Ansgar A., Klein M., Fiehe K. et al.: Occurrence of neurotoxic 4´-O-methylpyridoxine in Ginkgo biloba leaves, Ginkgo medications and Japanese Ginkgo food. Planta Med. 1996, 62, 548. 14. Tisserand R, Balacs T.: Essential oil safety. Edinburgh. Churchill Livingstone, 1995. 15. EMEA/HMPC/138381/2005. Public statement on the risk associated with the use of herbal products containing Aristolochia species. EMEA, London 2005. 16. Teuscher E., Lindequist U.: Biogene Gifte. Biologie-Chemie-Pharmakologie. Akademie-Verlag, Berlin 1988. 17. Nortier J.L., Martinez M.C., Schmeiser H.H. et al.: Urothelial carcinoma associated with the use of a Chinese herb ( Aristolochia fangchi). N. Engl. J. Med. 2000, 342, 1686. 18. EMEA/HMPC/139215/05. Public statement on the use of herbal medicinal products containing asarone. EMEA, London 2005. 19. Chandler R.F., Phillipson J.D., Anderson L.A.: Controversial laetrile. Pharm. J. 1984, 232-330. 20. EMEA/HMPC/137212/05. Public statement on the use of herbal medicinal products containing estragole. EMEA, London 2005. 21. Ljunggren B.: Severe phototoxic burn following celery ingestion. Arch .Dermatol. 1990, 126, 1334. 22. Boffa M.J., Gilmour E., Ead R.D.: Celery soup causing severe phototoxicity during PUVA therapy. Brit. J. Dermatol. 1996, 135, 330. 23. EMEA/HMPC/317913/2006. Reflection paper on the risk associated with furocoumarins contained in preparations of Angelica archangelica L. EMEA, London 2007. 24. Russmann S.: Kava hepatotoxicity. Ann Int. Med. 2001, 135, 68. 25. Geier F.P., Konstantinowicz T.: Kava treatment in patients with anxiety. Phytother. Res. 2004, 18, 297. 26. Anderson L.A., Phillipson J.D.: Mistletoe- the magic herb. Pharm. J. 1982, 229, 437. 27. EMEA/HMPC/138363/05. Public statement on the use of herbal medicinal products containing methyleugenol. EMEA, London 2005. 28. Gardner D.G.: Injury to the oral mucous membranes caused by the common houseplant, dieffenbachia. Oral Surg. Oral Med. Oral Pathol. 1994, 78, 631. 29. Lindsjo M.: Oxalate metabolism in renal stone disease with special reference to calcium metabolism and intestinal absorption. Scand. J. Urol. Nephrol. Suppl. 1989, 119, 1. 30. McGuffin M., Hobbs C., Upton R. et al.: American Herbal Products Association´s Botanical Safety Handbook. Boca Raton, CRC Press, USA 1997. 31. Kingsbury J.M.: Poisonous plants of the United States and Canada. Prentice-Hall Inc., 1964. 32. EMEA/HMPC/138386/05. Public statement on the use of herbal medicinal products containing pulegone and menthofuran. EMEA, London 2005. 33. Tyler V.E.: The Honest Herbal (3rd edn.). Howarth Press, New York 1993. 34. Baldwin C.A., Anderson L.A., Phillipson J.D.: What pharmacists should know about feverfew. Pharm. J. 1987, 239, 237. 35. Slifman N.R., Obermeyer W.R., Aloi B.K. et al.: Contamination of botanical dietary supplements by Digitalis lanata. N. Engl. J. Med. 1998, 339, 806. 36. Huang W.F., Wen K.C., Hsiao M.L.: Adulteration by synthetic therapeutic substances of traditional Chinese medicines in Taiwan. J. Clin. Pharmacol. 1997, 37, 344. 37. Koh H.L., Woo S.O.: Chinese proprietary medicine in Singapore: regulatory control of toxic heavy metals and undeclared drugs. Drug Safety 2000, 23, 351. 38. Williamson E.M.: Drugs interactions between herbal and prescription medicines. Drug Safety 2003, 26, 1075. 39. Fugh-Berman A.: Herb-drug interactions. The Lancet 2000, 355, 134.